oigonfreedrugs

November 22, 2005 Special Advisory Bulletin: Patient Assistance Programs for Medicare Part D Enrollees (November 2005) Drug manufacturers have historically helped low-income people by giving them free or low-cost medications for specific conditions. In light of the competitive focus of Medicare Part D, the OIG has ruled that any help a manufacturer gives must not interfere with the ability of a Medicare Part D program operator to provide care for enrollees. Donations of name brand medications may be viewed as interference with the operator's program by encouraging patients to request name brand drugs not covered by the . . .